The companies will combine clinical genetic testing services with data management technology to support precision medicine for rare diseases.
The Trump Administration plans to add DNA samples from individuals in immigration custody to the FBI crime database, the New York Times reports.
Arrests have been made and charges filed in connection with a genetic testing fraud scheme, Reuters reports.
Two lawsuits represent two sides of genetic testing, the Economist writes: to know or not your risk of developing disease.
A Japanese Kobe beef industry group is to begin using DNA testing to fight against fake Kobe beef, according to Kyodo News.
Reuters reports on the growth of genetic testing fraud in the US that targets senior citizens.
CBS This Morning highlights recent Medicare fraud involving offers of genetic testing.
CNN reports that Immigration and Customs Enforcement in the US has expanded its DNA testing to seven sites along the southern border.
Rhythm has a drug called setmelanotide in Phase III development for genetic obesity disorders associated with variants within the melanocortin-4 pathway.
NPR speaks with research participants before and after they learn their APOE E4 status, which affects their risk of developing Alzheimer's disease.
Russian CRISPR researcher moves along with plans to ultimately alter the genes of embryos of deaf couples, though awaits regulatory approval, Nature News reports.
University of California, San Francisco, researchers have uncovered a gene mutations that appears to make a father-son duo more efficient sleepers.
NPR reports a large health insurer has begun to cover some pharmacogenetic tests for psychiatric drugs.
In PLOS this week: genome-wide association study of non-syndromic orofacial cleft subtypes, epigenetic and transcriptomic analysis of pancreatic ductal adenocarcinoma, and more.